Mirabegron beats tamsulosin at easing ureteral stent symptoms in randomized trial
A randomized double-blind trial found mirabegron 50 mg daily outperformed tamsulosin 0.4 mg and placebo in reducing ureteral stent symptoms, ...
A randomized double-blind trial found mirabegron 50 mg daily outperformed tamsulosin 0.4 mg and placebo in reducing ureteral stent symptoms, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.